129 related articles for article (PubMed ID: 27487889)
1. Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment.
Hwang EJ; Kim HG; Kim D; Rhee HY; Ryu CW; Liu T; Wang Y; Jahng GH
Med Phys; 2016 Aug; 43(8):4718. PubMed ID: 27487889
[TBL] [Abstract][Full Text] [Related]
2. Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Rhee SJ; Lee SY; Wang Y; Jahng GH
Neuroimage Clin; 2017; 16():429-438. PubMed ID: 28879084
[TBL] [Abstract][Full Text] [Related]
3. Mapping of distributions of a local b-matrix cross-term strength using diffusion tensor MRI in patients with Alzheimer's disease.
Jahng GH; Xu S; Kim MJ
Med Phys; 2012 Oct; 39(10):6324-31. PubMed ID: 23039668
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and Prediction of Early Alzheimer's Disease Using a Machine Learning-based Optimized Combination-Feature Set on Gray Matter Volume and Quantitative Susceptibility Mapping.
Kim HG; Park S; Rhee HY; Lee KM; Ryu CW; Lee SY; Kim EJ; Wang Y; Jahng GH
Curr Alzheimer Res; 2020; 17(5):428-437. PubMed ID: 32579502
[TBL] [Abstract][Full Text] [Related]
5. Double inversion recovery imaging improves the evaluation of gray matter volume losses in patients with Alzheimer's disease and mild cognitive impairment.
Jahng GH; Lee DK; Lee JM; Rhee HY; Ryu CW
Brain Imaging Behav; 2016 Dec; 10(4):1015-1028. PubMed ID: 26497891
[TBL] [Abstract][Full Text] [Related]
6. A diagnostic index based on quantitative susceptibility mapping and voxel-based morphometry may improve early diagnosis of Alzheimer's disease.
Sato R; Kudo K; Udo N; Matsushima M; Yabe I; Yamaguchi A; Tha KK; Sasaki M; Harada M; Matsukawa N; Amemiya T; Kawata Y; Bito Y; Ochi H; Shirai T
Eur Radiol; 2022 Jul; 32(7):4479-4488. PubMed ID: 35137303
[TBL] [Abstract][Full Text] [Related]
7. The cerebellum shrinks faster than normal ageing in Alzheimer's disease but not in mild cognitive impairment.
Tabatabaei-Jafari H; Walsh E; Shaw ME; Cherbuin N;
Hum Brain Mapp; 2017 Jun; 38(6):3141-3150. PubMed ID: 28321950
[TBL] [Abstract][Full Text] [Related]
8. Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.
Moon Y; Han SH; Moon WJ
J Alzheimers Dis; 2016; 51(3):737-45. PubMed ID: 26890777
[TBL] [Abstract][Full Text] [Related]
9. 3D texture analyses within the substantia nigra of Parkinson's disease patients on quantitative susceptibility maps and R2
Li G; Zhai G; Zhao X; An H; Spincemaille P; Gillen KM; Ku Y; Wang Y; Huang D; Li J
Neuroimage; 2019 Mar; 188():465-472. PubMed ID: 30578927
[TBL] [Abstract][Full Text] [Related]
10. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
11. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.
Johnson NA; Jahng GH; Weiner MW; Miller BL; Chui HC; Jagust WJ; Gorno-Tempini ML; Schuff N
Radiology; 2005 Mar; 234(3):851-9. PubMed ID: 15734937
[TBL] [Abstract][Full Text] [Related]
12. Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease.
Namiki C; Takita Y; Iwata A; Momose T; Senda M; Okubo Y; Joshi AD; Lu M; Agbulos A; Breault C; Pontecorvo MJ
Ann Nucl Med; 2015 Aug; 29(7):570-81. PubMed ID: 25943346
[TBL] [Abstract][Full Text] [Related]
13. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity.
Binnewijzend MA; Kuijer JP; Benedictus MR; van der Flier WM; Wink AM; Wattjes MP; van Berckel BN; Scheltens P; Barkhof F
Radiology; 2013 Apr; 267(1):221-30. PubMed ID: 23238159
[TBL] [Abstract][Full Text] [Related]
14. R2* relaxometry analysis for mapping of white matter alteration in Parkinson's disease with mild cognitive impairment.
Kan H; Uchida Y; Ueki Y; Arai N; Tsubokura S; Kunitomo H; Kasai H; Aoyama K; Matsukawa N; Shibamoto Y
Neuroimage Clin; 2022; 33():102938. PubMed ID: 34998126
[TBL] [Abstract][Full Text] [Related]
15. Cortical Iron Accumulation as an Imaging Marker for Neurodegeneration in Clinical Cognitive Impairment Spectrum: A Quantitative Susceptibility Mapping Study.
Kim HW; Lee S; Yang JH; Moon Y; Lee J; Moon WJ
Korean J Radiol; 2023 Nov; 24(11):1131-1141. PubMed ID: 37899522
[TBL] [Abstract][Full Text] [Related]
16. Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
Basselerie H; Bracoud L; Zeestraten E; Bouguen E; Kiyasova V; Pueyo M; Cognard C; Dumas H; Gramada R; Ousset PJ; Vellas B; Bonneville F
J Alzheimers Dis; 2017; 60(1):253-262. PubMed ID: 28826188
[TBL] [Abstract][Full Text] [Related]
17. Discerning mild cognitive impairment and Alzheimer Disease from normal aging: morphologic characterization based on univariate and multivariate models.
Liao W; Long X; Jiang C; Diao Y; Liu X; Zheng H; Zhang L;
Acad Radiol; 2014 May; 21(5):597-604. PubMed ID: 24433704
[TBL] [Abstract][Full Text] [Related]
18. Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.
Vasavada MM; Martinez B; Wang J; Eslinger PJ; Gill DJ; Sun X; Karunanayaka P; Yang QX
J Alzheimers Dis; 2017; 59(1):359-368. PubMed ID: 28671131
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
[TBL] [Abstract][Full Text] [Related]
20. Detecting perfusion deficit in Alzheimer's disease and mild cognitive impairment patients by resting-state fMRI.
Yan S; Qi Z; An Y; Zhang M; Qian T; Lu J
J Magn Reson Imaging; 2019 Apr; 49(4):1099-1104. PubMed ID: 30318645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
